Not really sure I'd agree with that. We are using our cells in human trials now, with proven results over standard of care. maybe 2yrs away and we'll be one of the standards of care for some treatments
- Forums
- ASX - By Stock
- CYP
- Ann: First Kidney Transplant Trial Patient Treated
CYP
cynata therapeutics limited
Add to My Watchlist
8.82%
!
15.5¢

Ann: First Kidney Transplant Trial Patient Treated, page-10
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
15.5¢ |
Change
-0.015(8.82%) |
Mkt cap ! $35.02M |
Open | High | Low | Value | Volume |
17.0¢ | 17.0¢ | 15.5¢ | $35.01K | 213.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 201289 | 15.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 14675 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 201289 | 0.155 |
7 | 323545 | 0.150 |
4 | 81775 | 0.145 |
5 | 315005 | 0.140 |
1 | 5000 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.165 | 14675 | 1 |
0.170 | 26942 | 1 |
0.175 | 54733 | 2 |
0.180 | 165059 | 2 |
0.185 | 25916 | 1 |
Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |